Volume 21.21 | Jun 15

2020-06-25 | CTN 21.21
Cell Therapy News by STEMCELL Technologies
Vol. 21.21 – 15 June, 2020
TOP STORY

Long-Term Follow-Up of the First In Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 For Severe Hemophilia B

Scientists present longitudinal follow up data of subjects who participated in the first trial of a systemically-delivered adeno-associated viral (AAV) vector. Adult males with severe hemophilia B received an AAV2 vector at doses ranging from 8×1010 – 2×1012 vg/kg to target hepatocyte-specific expression of coagulation factor IX; a subset were followed for 12-15 years post vector administration.
[Molecular Therapy]

AbstractGraphical Abstract

Watch 'collaborating to accelerate COVID-19 research'
PUBLICATIONSRanked by the impact factor of the journal

Novel Delivery of Cellular Therapy to Reduce Ischemia Reperfusion Injury in Kidney Transplantation

The authors investigated the potential capability of multipotent adult progenitor cells in kidney normothermic machine perfusion.
[American Journal of Transplantation]

Abstract

Analysis of Aflibercept Expression in Non-Human Primates following Intravitreal Administration of ADVM-022, a Potential Gene Therapy for Neovascular Age-Related Macular Degeneration

Researchers explored whether ADVM-022, a recombinant adeno-associated virus vector designed to express aflibercept, could induce anti-VEGF protein levels comparable to those observed following a single bolus intravitreal injection of the standard-of-care aflibercept recombinant protein.
[Molecular Therapy-Methods & Clinical Development]

Abstract

Efficient CRISPR/Cas9-Mediated Gene Ablation in Human Keratinocytes to Recapitulate Genodermatoses: Modeling of Netherton Syndrome

Investigators have established a highly efficient method for precise deletion of critical gene sequences in primary human keratinocytes, based on CRISPR/Cas9-mediated gene editing.
[Molecular Therapy-Methods & Clinical Development]

AbstractGraphical Abstract

Neural Stem Cell Delivery via Porous Collagen Scaffolds Promotes Neuronal Differentiation and Locomotion Recovery in Spinal Cord Injury

Scientists demonstrated that grafts based on porous collagen-based scaffolds, similar to biomaterials utilized clinically in induced regeneration, could deliver and protect embryonic neural stem cells at spinal cord injury (SCI) sites, leading to significant improvement in locomotion recovery in an experimental mouse SCI model.
[NPJ Regenerative Medicine]

Full Article

Lentiviral Gene Therapy Rescues p47phox Chronic Granulomatous Disease and the Ability to Fight Salmonella Infection in Mice

Investigators tested the ability of a gene therapy approach to control infection by challenging p47phox-null mice with Salmonella Typhimurium, a leading cause of sepsis in chronic granulomatous diseasep atients, and found that mice reconstituted with lentivirus-transduced hematopoietic stem cells had a reduced bacterial load compared with untreated mice.
[Gene Therapy]

Full Article

Phase I Trial of Expanded, Activated Autologous NK Cell Infusions with Trastuzumab in Patients with HER2-Positive Cancers

The authors infused expanded, activated autologous natural killer cells to potentiate trastuzumab-mediated antibody-dependent cell cytotoxicity in patients with HER2-positive malignancies.
[Clinical Cancer Research]

Abstract

Comparison of the Regenerative Effects of Bone Marrow/Adipose-Derived Stem Cells in the Asherman Model following Local or Systemic Administration

Scientists compared the effects of systemic or local intrauterine injection of bone marrow or adipose-derived mesenchymal stem cells on the endometrium in a rat model of Asherman’s syndrome.
[Journal of Assisted Reproduction and Genetics]

Abstract

Recovery of Motricity and Micturition after Transplantation of Mesenchymal Stem Cells in Rats Subjected to Spinal Cord Injury

Investigators evaluated the effect of human adipose-derived stem cell infusion on impaired hindlimb function and urinary continence after spinal cord contusion in rats.
[Neuroscience Letters]

Abstract

Explore Antibodies for Immunology Research
REVIEWS

Advances in the Development of Gene Therapy, Noncoding RNA, and Exosome‐Based Treatments for Tendinopathy

The authors summarize the current understanding and treatments for tendinopathy. They also highlight recent advances in gene therapy, the potential of noncoding RNAs, such as microRNAs, and exosomes, which are nanometer‐sized extracellular vesicles secreted from cells, for the treatment of tendinopathy.
[Annals of the New York Academy of Sciences]

Abstract

INDUSTRY AND POLICY NEWS

Ovid Therapeutics Announces Strategic Research Collaboration Focused on Accelerating the Development of New Treatments for Rare Neurological Diseases

Ovid Therapeutics Inc. announced a strategic research collaboration with Columbia University Irving Medical Center researchers to advance genetic based therapies for a range of rare neurological conditions, complementary to Ovid’s current pipeline.
[Ovid Therapeutics Inc.]

Press Release

City of Hope Signs Licensing Agreement with Scopus BioPharma Inc. to Develop Novel, Targeted Immuno-Oncology Gene Therapy

City of Hope signed an exclusive, worldwide licensing agreement with Scopus BioPharma Inc. Scopus will further develop and plans to commercialize a City of Hope first-in-class, targeted immuno-oncology gene therapy.
[City of Hope]

Press Release

FEATURED EVENT

International Society for Stem Cell Research (ISSCR) Virtual Annual Meeting 2020

2020-06-23 – 2020-06-27
Virtual

> See All Events

JOB OPPORTUNITIES

Postdoctoral Fellow – Immune and Stem Cell Engineering

Terasaki Institute for Biomedical Innovation – Los Angeles, California, United States

Faculty Positions – Regenerative Medicine

Guangzhou Regenerative Medicine and Health Guangdong Laboratory – Guangzhou, China

Chair – Bioengineering

University of Washington – Seattle, Washington, United States

Lab Director – Cancer Immunotherapy

Vrije Universiteit Brussels – Brussels, Belgium

Principal Scientist – Human iPSC Gene Engineering

Empyrean Therapeutics Ltd – Cambridge, United Kingdom

Postdoctoral Position – RNA Editing and Immunotherapy

University of Chicago – Chicago, Ilinois, United States

Postdoctoral Fellow – CRISPR Research

Boston Children’s Hospital – Boston, Massachusetts, United States

Postdoctoral Fellow – Cancer Adoptive Cell Immunotherapy

Wake Forest School of Medicine – Winston Salem, North Carolina, United States

Postdoctoral Position – CRISPR/Cas Genetic Engineering

Aarhus University – Aarhus C, Denmark

Professor Positions – Biomedical Sciences

The Chinese University of Hong Kong – Hong Kong, China

> See All Jobs

Submit an article, publication, job or event
Brought to you by
stemcell-logo-for newsletter-2
Cell Therapy News Twitter